Edguider Online Blog on ED, viagra, cialis and levitra

ED, or what we don’t like to say out loud, Erectile Dysfunction. Viagra has turned ED into something almost akin to fashionable. Then Cialis and Levitra got tossed into the mix and presto, a treatment option for men who suffer from ED. What’s the next obstacle to hurdle that men do not wish to talk about? Premature Ejaculation. Or wait; let’s call this one something cool too, how about PE?

Research is beginning to show that PE is actually affecting more men than ED, actually 1 in 3 men are affected. Atlanta based Sciele Pharma’s senior product manager says “it’s a huge unmet need”.

Both Johnson & Johnson and Sciele Pharma are hoping to capitalize on the next Viagra which had worldwide sales last year of about 1.93 billion. Both are currently awaiting FDA (Food and Drug Administration) approval.

Sciele Pharma is marketing a metered dose aerosol which is sprayed on the penis to increase latency time. Company reps are meeting journalist’s and attending medical conferences to drum up sympathy for PE. They want to call attention to PE and make it a medical problem in which they will provide a prescription drug solution.

Priligy has come out of the Johnson and Johnson camp which takes aim at Premature Ejaculation in a pill form also aimed at increasing latency before orgasm. This would be welcome to men who ejaculate before or shortly after the act of intercourse. Priligy actually went on sale last year in none other countries such as Sweden, Germany and Spain but is still awaiting approval in the USA.

Dr. Hellstrom claims the actual PE numbers stand at about 20-30%. Hellstrom, who has consulted for Johnson & Johnson, is a professor of urology at the Tulane University School of Medicine in New Orleans.

The 1 in 3 numbers come from a study based on a 1992 survey which included questions on fidelity. Sexologists dispute these numbers as the study was not geared toward answering sexual health questions.

Sciele’s spray on application has shown to increase the time to orgasm to 2.6 minutes, up from 36 seconds. So now how do marketers convince the health care sector and the general public that this is a serious enough issue to create a whole new marketable disease?

Viagra did it. Pfizer introduced the drug in 1998, creating the only medication for treating ED. They started out something like this; Make people aware of a quality of life issue that does not yet have a prescription to help this issue. Next, have a medical condition created with symptoms so common that it covers a huge population segment, thus indentifying them as having a health problem.

No doubt PE can be distressing for men; there is little evidence that premature ejaculation is an epidemic. Let’s see what is yet to come for treating minute men who suffer from premature ejaculation, there are a few options in the works, let’s see if there will be one that might become as popular as Viagra but for PE.